AI Infrastructure

The latest AI Infrastructure posts we have indexed from venture capital blogs and newsletters, plus the highest-scoring pieces of the past year and the people who write about it most.

Best of the past year
  • 2026: The State of Enterprise AI Menlo VC · 3 Nov 2026

    Enterprise AI deployment spending surged 5.4x to $177B in 2026, driven by autonomous agents that now consume 80% of model tokens and enable new use cases in coding and customer support; frontier models command 69% of spend despite open-source gaining usage share.

  • 7 Days to $100M, 5 Days to Free makers + builders · 14 Oct 2026

    Decision models—a new AI category that makes bounded choices rather than generating text—launched at $100M revenue in a week, then got replicated for $95 in open-source form within five days, signaling that software commoditization has reached a new inflection where defensibility now rests on integration and operations rather than capability alone.

  • Venture capital is shifting from software to physical technologies as AI collapses software development costs and the SaaS model loses defensibility; the strongest opportunities now lie at the intersection of AI-accelerated atoms—chips, energy, robotics, biotech—where capital intensity and technical moats remain defensible.

  • AGI, unevenly distributed makers + builders · 4 Sept 2026

    Software AGI has arrived as of November 2025, but only in coding; the real frontier is verification, not generation. Meanwhile, capability gaps in medicine and security reveal the pattern—models can do the work, but humans haven't scaled to review it.

  • As AI capex bubbles and shifts to local deployment, robotics emerges as the natural "application layer"—but mass adoption depends on extensibility, cheap hardware, and hobbyist-driven innovation, mirroring how personal computers displaced mainframes.

  • The Jensen Era Ends Aspiring for Intelligence · 13 Nov 2026

    Nvidia's leadership crisis and market turmoil are testing AI's venture funding thesis; Anthropic's IPO pricing will signal whether a valuation reset extends from public markets into private AI rounds, with Nvidia's balance-sheet support for infrastructure as the transmission mechanism.

  • AI is reshaping drug discovery economics by improving success rates and reducing development time and cost, potentially enabling pharma companies to earn "valuation credit" like software businesses and spawning a wave of AI-native biotech startups building discovery platforms or their own therapeutics.

  • Inference providers compete in a thin-margin compute commodity today, but the few that execute AWS's playbook—cutting prices on raw GPUs while climbing the stack to sell higher-value products like fine-tuning and custom model serving—could build durable, high-margin businesses with real customer lock-in.

Who writes about AI Infrastructure

Tomasz Tunguz (33) · Lightspeed Venture Partners (31) · Saanya Ojha (23) · Newcomer (14) · Investing in AI (13) · Ed Sim (13) · A16Z (13) · Radical VC (10) · USV (8) · Clouded Judgement (8)

Recent
Other topics
AI (Horizontal)Enterprise SoftwareDeveloper ToolsData & AnalyticsCybersecurityFintechInsuranceBanking & Capital MarketsCrypto & Web3HealthcareBiotech & Life SciencesConsumerAll topics